BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 7133597)

  • 1. Distribution of estrogen and progesterone receptors on primary tumor and lymph nodes in individual patients with breast cancer.
    Klinga K; Kaufmann M; Runnebaum B; Kubli F
    Oncology; 1982; 39(6):337-9. PubMed ID: 7133597
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distribution of estrogen and progesterone receptors in primary tumor and lymph nodes in individual patients with breast cancer.
    Coradini D; Cappelletti V; Miodini P; Ronchi E; Scavone G; Di Fronzo G
    Tumori; 1984 Apr; 70(2):165-8. PubMed ID: 6730015
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Absent progesterone receptor expression in the lymph node metastases of ER-positive, HER2-negative breast cancer is associated with relapse on tamoxifen.
    Snell CE; Gough M; Middleton K; Hsieh M; Furnas L; Seidl B; Gibbons K; Pyke C; Shannon C; Woodward N; Armes JE
    J Clin Pathol; 2017 Nov; 70(11):954-960. PubMed ID: 28416639
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HER-2, ER, PR status concordance in primary breast cancer and corresponding metastatic lesion in lymph node in Chinese women.
    Li MH; Hou CL; Wang C; Sun AJ
    Pathol Res Pract; 2016 Apr; 212(4):252-7. PubMed ID: 26899763
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunohistochemical detection of estrogen and progesterone receptors in primary breast cancer.
    Chariyalertsak S; Chariyalertsak S; Ruangvejvorachi P
    Asian Pac J Allergy Immunol; 1998 Dec; 16(4):161-6. PubMed ID: 10219897
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Estrogen and progesterone receptors of primary breast carcinoma and their axillary lymph node metastases--immunohistochemical investigations of routine formalin-fixed paraffin-embedded tissue].
    Schulze MH; Buchmann J
    Zentralbl Gynakol; 2000; 122(2):92-5. PubMed ID: 10721188
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Breast cancer estrogen and progesterone receptor values: their distribution, degree of concordance, and relation to number of positive axillary nodes.
    Fisher B; Wickerham DL; Brown A; Redmond CK
    J Clin Oncol; 1983 Jun; 1(6):349-58. PubMed ID: 6668505
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distribution, frequency, and quantitative analysis of estrogen, progesterone, androgen, and glucocorticoid receptors in human breast cancer.
    Allegra JC; Lippman ME; Thompson EB; Simon R; Barlock A; Green L; Huff KK; Do HM; Aitken SC
    Cancer Res; 1979 May; 39(5):1447-54. PubMed ID: 427788
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Axillary lymph node status of operable breast cancers by combined steroid receptor and HER-2 status: triple positive tumours are more likely lymph node positive.
    Van Calster B; Vanden Bempt I; Drijkoningen M; Pochet N; Cheng J; Van Huffel S; Hendrickx W; Decock J; Huang HJ; Leunen K; Amant F; Berteloot P; Paridaens R; Wildiers H; Van Limbergen E; Weltens C; Timmerman D; Van Gorp T; Smeets A; Van den Bogaert W; Vergote I; Christiaens MR; Neven P
    Breast Cancer Res Treat; 2009 Jan; 113(1):181-7. PubMed ID: 18264760
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of tumor size and axillary lymph node metastasis on estrogen and progesterone receptors in primary breast cancer.
    Alghanem AA; Hussain S
    J Surg Oncol; 1986 Mar; 31(3):218-21. PubMed ID: 3724175
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Immunohistochemical investigation of estrogen and progesterone receptors in breast tumors].
    Ellinidi VN; Anikseeva NV; Goncharova OA; Krasnozhon DA; Fedorov KA
    Vopr Onkol; 2004; 50(2):234-6. PubMed ID: 15176229
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of tumor estrogen and progesterone receptor levels on the response to tamoxifen and chemotherapy in primary breast cancer.
    Fisher B; Redmond C; Brown A; Wickerham DL; Wolmark N; Allegra J; Escher G; Lippman M; Savlov E; Wittliff J
    J Clin Oncol; 1983 Apr; 1(4):227-41. PubMed ID: 6366135
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunohistochemistry on cell blocks from fine-needle cytopunctures of primary breast carcinomas and lymph node metastases.
    Briffod M; Hacène K; Le Doussal V
    Mod Pathol; 2000 Aug; 13(8):841-50. PubMed ID: 10955449
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of an immunocytochemical assay for progesterone receptor with a biochemical method of measurement and immunocytochemical examination of the relationship between progesterone and estrogen receptors.
    Berger U; Wilson P; Thethi S; McClelland RA; Greene GL; Coombes RC
    Cancer Res; 1989 Sep; 49(18):5176-9. PubMed ID: 2766287
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Breast cancers negative for estrogen receptor but positive for progesterone receptor, a true entity?
    Kiang DT; Kollander R
    J Clin Oncol; 1987 Apr; 5(4):662-6. PubMed ID: 2435857
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical association of progesterone receptor isoform A with breast cancer metastasis consistent with its unique mechanistic role in preclinical models.
    Rosati R; Oppat K; Huang Y; Kim S; Ratnam M
    BMC Cancer; 2020 Jun; 20(1):512. PubMed ID: 32493230
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of ER, PR and HER-2/neu (C-erb B 2) reactivity pattern with histologic grade, tumor size and lymph node status in breast cancer.
    Azizun-Nisa ; Bhurgri Y; Raza F; Kayani N
    Asian Pac J Cancer Prev; 2008; 9(4):553-6. PubMed ID: 19256737
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Steroid receptor status and its clinicopathological correlation in post-menopausal breast cancer patients of Kumaon region of Uttarakhand.
    Shahi KS; Bhandari G; Singh A
    J Cancer Res Ther; 2011; 7(1):19-22. PubMed ID: 21546737
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Loss of hormonal receptors expression from primary breast carcinoma to axillary lymph node metastases].
    Cianga C; Cianga P; Cozma L; Diaconu C; Carasevici E
    Rev Med Chir Soc Med Nat Iasi; 2003; 107(3):540-4. PubMed ID: 14756058
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Simultaneous immunohistochemical and biochemical hormone receptor assessment in breast cancer provides complementary prognostic information.
    Biesterfeld S; Schröder W; Steinhagen G; Koch R; Veuskens U; Schmitz FJ; Handt S; Böcking A
    Anticancer Res; 1997; 17(6D):4723-9. PubMed ID: 9494596
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.